The Impact of the COVID-19 Pandemic on Patient Disparities in Long-Term Opioid Therapy.

Autor:	Tong ST; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Zheng Z; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Prado MG; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., West II; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., LeMaster JW; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Hatch MA; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Szabo LS; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Anastas TM; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Ma KPK; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL)., Stephens KA; From the University of Washington, Seattle, WA (STT, ZZ, MGP, IIW, MAH, LSS, TMA, KPKM, KAS); University of Kansas Medical Center , Kansas City, KS (JWL).
Jazyk:	angličtina
Zdroj:	Journal of the American Board of Family Medicine : JABFM [J Am Board Fam Med] 2024 Mar-Apr; Vol. 37 (2), pp. 290-294.
DOI:	10.3122/jabfm.2023.230359R1
Abstrakt:	Background: The COVID-19 pandemic disrupted how primary care patients with chronic pain received care. Our study sought to understand how long-term opioid therapy (LtOT) for chronic pain changed over the course of the pandemic overall and for different demographic subgroups. Methods: We used data from electronic health records of 64 primary care clinics across Washington state and Idaho to identify patients who had a chronic pain diagnosis and were receiving long-term opioid therapy. We defined 10-month periods in 2019 to 2021 as prepandemic, early pandemic and late pandemic and used generalized estimating equations analysis to compare across these time periods and demographic characteristics. Results: We found a proportional decrease in LtOT for chronic pain in the early months of the pandemic (OR = 0.94, P = .007 ) followed by an increase late pandemic (OR = 1.08, P = .002 ). Comparing late pandemic to prepandemic, identifying as Asian or Black, having fewer comorbidities, or living in an urban area were associated with higher likelihood of being prescribed LtOT. Discussion: The use of LtOT for chronic pain in primary care has increased from before to after the COVID-19 pandemic with racial/ethnic and geographic disparities. Future research is needed to understand these disparities in LtOT and their effect on patient outcomes. Competing Interests: Conflict of interest: None. (© Copyright 2024 by the American Board of Family Medicine.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu